| Primary |
| Product Used For Unknown Indication |
36.2% |
| Drug Use For Unknown Indication |
35.7% |
| Hypertension |
10.0% |
| Atrial Fibrillation |
5.7% |
| Arrhythmia |
1.1% |
| Supraventricular Tachycardia |
1.1% |
| Ill-defined Disorder |
1.0% |
| Overdose |
0.9% |
| Suicide Attempt |
0.8% |
| Cardiac Failure |
0.8% |
| Cluster Headache |
0.8% |
| Migraine |
0.8% |
| Blood Pressure |
0.7% |
| Depression |
0.7% |
| Rheumatoid Arthritis |
0.7% |
| Angina Pectoris |
0.6% |
| Blood Pressure Increased |
0.6% |
| Suicidal Ideation |
0.6% |
| Bronchitis |
0.6% |
| Completed Suicide |
0.6% |
|
| Completed Suicide |
29.0% |
| Death |
20.9% |
| Overdose |
5.5% |
| Vomiting |
4.9% |
| Poisoning |
4.4% |
| Drug Interaction |
4.2% |
| Medication Error |
3.2% |
| Poisoning Deliberate |
3.2% |
| Toxicity To Various Agents |
3.2% |
| Suicide Attempt |
2.6% |
| Syncope |
2.6% |
| Respiratory Arrest |
2.4% |
| Cardio-respiratory Arrest |
2.1% |
| Intentional Overdose |
2.1% |
| Off Label Use |
1.9% |
| Drug Toxicity |
1.8% |
| Shock |
1.6% |
| Circulatory Collapse |
1.5% |
| Gastrointestinal Haemorrhage |
1.5% |
| Hypotension |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
39.4% |
| Drug Use For Unknown Indication |
17.9% |
| Hypertension |
12.2% |
| Atrial Fibrillation |
6.6% |
| Drug Abuse |
5.2% |
| Bacteraemia |
2.9% |
| Suicide Attempt |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Depression |
1.8% |
| Type 2 Diabetes Mellitus |
1.4% |
| Blood Pressure Increased |
1.0% |
| Cluster Headache |
0.9% |
| Anxiety |
0.8% |
| Diabetes Mellitus |
0.8% |
| Pneumonia |
0.8% |
| Ill-defined Disorder |
0.8% |
| Cardiac Disorder |
0.7% |
| Hyperlipidaemia |
0.7% |
| Migraine |
0.6% |
| Toxic Epidermal Necrolysis |
0.6% |
|
| Completed Suicide |
28.7% |
| Hallucination |
10.8% |
| Toxicity To Various Agents |
8.0% |
| Poisoning |
5.7% |
| Vomiting |
5.3% |
| Toxic Epidermal Necrolysis |
4.8% |
| Death |
3.5% |
| Drug Toxicity |
3.3% |
| Syncope |
3.3% |
| Somnolence |
3.2% |
| Overdose |
3.0% |
| Respiratory Arrest |
3.0% |
| Ventricular Fibrillation |
2.7% |
| Myositis |
2.6% |
| Transaminases Increased |
2.4% |
| Drug Interaction |
2.2% |
| Hypotension |
1.9% |
| Nausea |
1.9% |
| Cardio-respiratory Arrest |
1.8% |
| Drug Ineffective |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.3% |
| Drug Use For Unknown Indication |
16.5% |
| Hypertension |
15.6% |
| Atrial Fibrillation |
4.2% |
| Pain |
4.0% |
| Rheumatoid Arthritis |
3.9% |
| Asthma |
3.7% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Depression |
3.1% |
| Diabetes Mellitus |
3.1% |
| Blood Cholesterol Increased |
2.8% |
| Osteoporosis |
2.6% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Migraine |
2.2% |
| Prophylaxis |
1.9% |
| Anxiety |
1.8% |
| Blood Pressure |
1.6% |
| Arthritis |
1.4% |
| Cardiac Disorder |
1.4% |
| Multiple Sclerosis |
1.4% |
|
| Vomiting |
13.6% |
| Weight Decreased |
10.8% |
| Weight Increased |
6.8% |
| Nausea |
5.6% |
| Pain |
5.5% |
| Drug Ineffective |
5.3% |
| Pneumonia |
4.4% |
| Myocardial Infarction |
4.4% |
| Pulmonary Embolism |
4.3% |
| Vision Blurred |
4.3% |
| Dyspnoea |
4.0% |
| Pain In Extremity |
3.8% |
| Headache |
3.7% |
| Rash |
3.6% |
| Pruritus |
3.5% |
| Renal Failure |
3.4% |
| Death |
3.3% |
| Syncope |
3.3% |
| Urinary Tract Infection |
3.2% |
| Oedema Peripheral |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
21.0% |
| Hypertension |
17.6% |
| Atrial Fibrillation |
10.3% |
| Drug Use For Unknown Indication |
10.3% |
| Hydrops Foetalis |
3.4% |
| Tachycardia Foetal |
3.4% |
| Anticoagulant Therapy |
3.1% |
| Blood Pressure |
3.1% |
| Coccidioidomycosis |
3.1% |
| Pain |
3.1% |
| Smoking Cessation Therapy |
3.1% |
| Arrhythmia Supraventricular |
2.3% |
| Kidney Infection |
2.3% |
| Sepsis |
2.3% |
| Urinary Tract Infection |
2.3% |
| Asthma |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Breast Cancer |
1.9% |
| Diuretic Therapy |
1.9% |
| Headache |
1.9% |
|
| Torsade De Pointes |
11.8% |
| Drug Interaction |
10.5% |
| Heart Rate Decreased |
9.2% |
| Rhabdomyolysis |
9.2% |
| Foetal Death |
5.3% |
| Gastrointestinal Haemorrhage |
5.3% |
| Hypotension |
5.3% |
| Respiratory Failure |
5.3% |
| Tendon Disorder |
5.3% |
| Transaminases Increased |
5.3% |
| Fatigue |
3.9% |
| Malaise |
3.9% |
| Therapeutic Response Unexpected |
3.9% |
| Atrial Fibrillation |
2.6% |
| Drug Therapeutic Incompatibility |
2.6% |
| Migraine |
2.6% |
| Myopathy |
2.6% |
| Skin Disorder |
2.6% |
| Atrioventricular Block |
1.3% |
| Dizziness |
1.3% |
|
